We are live on ! Find out more
American Century Companies

American Century Companies Portfolio holdings

AUM $226B
1-Year Est. Return 44.75%
 

American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.

This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+44.75%
3 Year Est. Return
+129.82%
5 Year Est. Return
+162.92%
10 Year Est. Return
+913.62%
AUM
$130B
AUM Growth
-$3.02B
Cap. Flow
+$2.27B
Cap. Flow %
1.75%
Top 10 Hldgs %
22.66%
Holding
2,931
New
141
Increased
1,882
Reduced
655
Closed
91

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$280M
2
KVUE icon
Kenvue
KVUE
+$272M
3
NSC icon
Norfolk Southern
NSC
+$240M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$234M
5
AMZN icon
Amazon
AMZN
+$183M

Sector Composition

Rank Sector Weight
1 Technology 23.02%
2 Healthcare 13.44%
3 Financials 13.33%
4 Consumer Discretionary 11.78%
5 Industrials 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSTX
2726
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$35.3K ﹤0.01%
14,844
+2,367
+19% +$4.96K
ATYR
2727
aTyr Pharma
ATYR
$53M
$34.9K ﹤0.01%
22,080
+7,889
+56% +$14.6K
LONA
2728
LeonaBio Inc
LONA
$73.9M
$30.8K ﹤0.01%
+1,527
New +$39.1K
IMUX icon
2729
Immunic
IMUX
$217M
$30.8K ﹤0.01%
+2,094
New +$40.3K
NKTX icon
2730
Nkarta
NKTX
$171M
$30.3K ﹤0.01%
21,817
+8,177
+60% +$15.5K
ACET icon
2731
Adicet Bio
ACET
$77.3M
$29.9K ﹤0.01%
1,362
+303
+29% +$10.7K
THRX
2732
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$28.3K ﹤0.01%
+10,514
New +$41.2K
PYXS icon
2733
Pyxis Oncology
PYXS
$201M
$27.4K ﹤0.01%
+13,771
New +$31.9K
CRVS icon
2734
Corvus Pharmaceuticals
CRVS
$1.27B
$27.4K ﹤0.01%
+18,754
New +$39.7K
OMGA
2735
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$26.3K ﹤0.01%
+12,225
New +$48.9K
RGTI icon
2736
Rigetti Computing
RGTI
$6.15B
$22.4K ﹤0.01%
+16,815
New +$32.3K
DMTK
2737
DELISTED
DermTech, Inc. Common Stock
DMTK
$22.1K ﹤0.01%
+15,348
New +$38.4K
KNTE
2738
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$20.9K ﹤0.01%
+14,906
New +$35.8K
GAU
2739
Galiano Gold
GAU
$547M
$19.7K ﹤0.01%
32,966
-5,000
-13% -$3.11K
ADVM
2740
DELISTED
Adverum Biotechnologies
ADVM
$19.6K ﹤0.01%
+1,306
New +$23.4K
WULF icon
2741
TeraWulf
WULF
$8.58B
$16.1K ﹤0.01%
+12,782
New +$30.3K
CANG
2742
Cango Inc
CANG
$89.8M
$12.1K ﹤0.01%
1,019
PLBY icon
2743
Playboy Inc
PLBY
$149M
$11K ﹤0.01%
+13,681
New +$19.6K
AGEN
2744
Agenus
AGEN
$311M
-853
Closed -$27.3K
ALIT icon
2745
Alight
ALIT
$377M
-1,299
Closed -$240K
AMC icon
2746
AMC Entertainment Holdings
AMC
$2.26B
-3,625
Closed -$160K
AMWL icon
2747
American Well
AMWL
$215M
-6,639
Closed -$279K
APLS
2748
DELISTED
Apellis Pharmaceuticals
APLS
-4,626
Closed -$421K
ASR icon
2749
Grupo Aeroportuario del Sureste
ASR
$8.24B
-11,678
Closed -$3.24M
ATRA icon
2750
Atara Biotherapeutics
ATRA
$83.1M
-585
Closed -$23.6K

Similar funds

American Century Companies's Q3 2023 Portfolio in Review

As of Q3 2023, American Century Companies held 2,931 positions worth $130B, down 2.3% from $133B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

American Century Companies's Q3 2023 filing shows 141 new, 1,882 increased, 655 reduced and 91 closed positions. Its largest new stake was Seadrill: 2,264,354 shares worth $101M. The largest sale was Marvell Technology, an estimated $251M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • American Century Companies's largest Q3 2023 buy was Seadrill: 2,264,354 shares worth $101M.
  • American Century Companies added most to NVIDIA in Q3 2023, an estimated $280M increase.
  • American Century Companies's biggest Q3 2023 reduction was Marvell Technology, cutting an estimated $251M.
  • American Century Companies fully exited AngloGold Ashanti in Q3 2023, selling an estimated $39.7M.
  • American Century Companies's ten largest holdings make up 23% of its $130B portfolio in Q3 2023.
  • American Century Companies opened 141 new positions and closed 91 in Q3 2023.
  • American Century Companies's portfolio value fell 2.3% quarter-over-quarter to $130B.

Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.